BCL2 and neoplasm: In addition, we correlated the results with the expression of the molecular markers (apoptotic and tumor survival) Ki67, Bcl-2, CD10 and syndecan-1 (CD138) for which a prognostic significance in prostate cancer has previously been suggested [14–19].